The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call
1 Stock Under $10 with Exciting Potential and 2 Facing Headwinds
CLOV Q2 Deep Dive: AI Adoption, Cohort Maturation Drive Growth and Guidance Upside
Clover Health’s (NASDAQ:CLOV) Q2 CY2026 Sales Top Estimates, Stock Jumps 10.3%
Barchart Research What to Expect from CLOV Earnings CLOV Generated August 4, 2026 Current Price $4.26 Consensus Rating Moderate Buy Average Move 9.09% Clover Health's Earnings Arrive With Expectations...
Clover Health (CLOV) To Report Earnings Tomorrow: Here Is What To Expect
WILMINGTON, Del., July 22, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial...
WILMINGTON, Del., July 09, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its...
SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or “Clover Health”),...
1 Cash-Heavy Stock on Our Buy List and 2 Facing Challenges